Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Morrish

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Endocrinological Investigation|April 21, 2001
Graves' disease presenting as hemiparkinsonismJ S Davies, P K Morrish, M F Scanlon
Journal of Neurology, Neurosurgery, and Psychiatry|December 28, 1999
Leukoencephalopathy associated with khat misuseP K Morrish, N Nicolaou, P Brakkenberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 1998
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PETP K Morrish, J S Rakshi, D L Bailey, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET studyJ S Rakshi, N Pavese, T Uema, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 1999
Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's diseaseK Ito, P K Morrish, J S Rakshi, et al.
Neurology|July 1, 1994
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's diseaseG V Sawle, D J Burn, P K Morrish, et al.
Brain : a Journal of Neurology|September 1, 1999
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET studyJ S Rakshi, T Uema, K Ito, et al.
Annals of Neurology|February 1, 1997
Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography studyP Piccini, P K Morrish, N Turjanski, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Endocrinological Investigation|April 21, 2001
Graves' disease presenting as hemiparkinsonismJ S Davies, P K Morrish, M F Scanlon
Journal of Neurology, Neurosurgery, and Psychiatry|December 28, 1999
Leukoencephalopathy associated with khat misuseP K Morrish, N Nicolaou, P Brakkenberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 1998
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PETP K Morrish, J S Rakshi, D L Bailey, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET studyJ S Rakshi, N Pavese, T Uema, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 1999
Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's diseaseK Ito, P K Morrish, J S Rakshi, et al.
Neurology|July 1, 1994
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's diseaseG V Sawle, D J Burn, P K Morrish, et al.
Brain : a Journal of Neurology|September 1, 1999
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET studyJ S Rakshi, T Uema, K Ito, et al.
Annals of Neurology|February 1, 1997
Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography studyP Piccini, P K Morrish, N Turjanski, et al.
Pageof 2